Patents by Inventor Xing Cheng

Xing Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230076811
    Abstract: A method and apparatus is disclosed relating to food processing and preparation in commercial kitchens. The disclosed extreme vacuum cooling (EVC) technology and apparatus can work in ultra low pressure conditions with adaptive pressure control to avoid potential liquid splash inside the vacuum chamber caused by un-controlled low pressure conditions. Clean air or inert gas is added into the vacuum chamber so that the chamber pressure can track a setpoint trajectory that may have ramp up periods in order to avoid liquid splash events. The inventive apparatus allows the user to automatically cool various kinds of foods based on a recipe with minimal human interaction and meet food safety regulations. Different cooling recipes can be created based on the type and volume of the foods and a related vacuum pressure setpoint trajectory. High-volume food service kitchens can achieve less labor intensive, more time efficient, and higher throughput food preparation operations.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 9, 2023
    Inventors: George Shu-Xing Cheng, David Kung-Tin Shao
  • Publication number: 20230025834
    Abstract: Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of lipoprotein signal peptidase II (LspA), a key protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
    Type: Application
    Filed: September 10, 2021
    Publication date: January 26, 2023
    Applicant: Genentech, Inc.
    Inventors: Guosheng WU, Emily J. HANAN, Marie-Gabrielle BRAUN, Sharada S. LABADIE, Keira GARLAND, Richard M. PASTOR, Paul Anthony GIBBONS, Yuhong FU, Yun-Xing CHENG
  • Publication number: 20230022920
    Abstract: A system and computer software mechanism is disclosed that can automatically detect smoking conditions for industrial flares. In an online mode, the software mechanism can analyze live video images to identify smoking conditions and generate a “Smoke Level” value to represent the seriousness of the smoking events. In an off-line mode, the software mechanism can load saved video files and analyze video images to identify smoking conditions and generate a “Smoke Level” value to represent the seriousness of the smoking events. In the online mode, the Smoke Level data can be sent to the plant distributed control system (DCS) or other control devices so alarms can be generated and automatic or manual control actions can be taken quickly to stop the flare from smoking. In both online and off-line modes, Smoke Level data can also be saved in historical files for reporting and smoke event tracking purposes.
    Type: Application
    Filed: September 30, 2022
    Publication date: January 26, 2023
    Inventors: George Shu-Xing Cheng, Andrew J. Chow, Manuel Martinez
  • Publication number: 20230016791
    Abstract: wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
    Type: Application
    Filed: August 24, 2022
    Publication date: January 19, 2023
    Applicant: Genentech, Inc.
    Inventors: Mark Edward Zak, Naomi S. Rajapaksa, Yun-Xing Cheng, Jessica Marie Grandner, Daniel G.M. Shore, Marian C. Bryan
  • Publication number: 20220411852
    Abstract: Provided is a composition for detecting multiple encephalitis/meningitis/respiratory pathogens. The composition includes primer sequences for the pathogens as shown in SEQ ID NOs: 1-7, 9-23 and 25-32, in which SEQ ID NOs: 1-7 and 9-16 carry fluorescent reporter groups. In addition, the present invention further provides a use of the foregoing composition in the preparation of a kit, and a related kit and a method for using the same.
    Type: Application
    Filed: September 2, 2022
    Publication date: December 29, 2022
    Inventors: Lizhong Dai, Deyong TAN, Zhongping DENG, Jia LIU, Xiaomei REN, Xing CHENG, Qingzhi SUN
  • Patent number: 11471499
    Abstract: The present invention provides methods for inducing regression of tumors in human subjects, the methods utilize a modified mesogenic strain of Newcastle disease virus (NDV) with modified F protein cleavage site, which is non-pathogenic to poultry (lentogenic), but exhibits oncolytic properties. The disclosed methods provide safe, effective and reliable means to induce regression of a tumor in an individual in need thereof. These methods overcome the drawbacks of using pathogenic strains of viruses for human therapy.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: October 18, 2022
    Assignee: MEDIMMUNE LIMITED
    Inventors: Xing Cheng, Danielle Carroll, Matthew McCourt, Mark Galinski, Hong Jin
  • Patent number: 11462089
    Abstract: A method and system is disclosed that can automatically detect smoking conditions for industrial flares. It can analyze live or historical video images to identify smoking conditions and generate a “Smoke Level” value in the range of 0 to 10 to represent the seriousness of the smoking events. The Smoke Level data can be sent to the plant distributed control system (DCS) or other control devices so alarms can be generated and automatic or manual control actions can be taken to stop the flare from smoking quickly. The Smoke Level data can also be saved in historical files for reporting and smoke event tracking purposes. Using the described method and system, industrial plants can comply with EPA regulations at all times, improve flare control and monitoring, be better prepared for EPA reporting and auditing, and save energy and manpower.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: October 4, 2022
    Assignee: General Cybernation Group, Inc.
    Inventors: George Shu-Xing Cheng, Andrew J. Chow, Manuel Martinez
  • Patent number: 11453671
    Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: September 27, 2022
    Assignee: Genentech, Inc.
    Inventors: Mark Edward Zak, Naomi S. Rajapaksa, Yun-Xing Cheng, Jessica Grandner, Daniel G. M. Shore, Marian C. Bryan
  • Publication number: 20220281893
    Abstract: Provided herein are tetracyclic oxazepinyl compounds useful in the treatment on cancers.
    Type: Application
    Filed: February 7, 2022
    Publication date: September 8, 2022
    Applicant: Genentech, Inc.
    Inventors: Lewis J. GAZZARD, Samantha Alyson GREEN, Matthew Leo LANDRY, Sushant MALHOTRA, Michael SIU, Steven DO, Yun-Xing CHENG, Limin CHENG, Jianfeng XIN, Mingtao HE
  • Publication number: 20220204517
    Abstract: Compounds of Formula (00A) and salts thereof, wherein R1, R2 R3, R4 and n are defined herein, are useful as inhibitors of one or more Janus kinases. Also provided are pharmaceutical compositions that include a compound of Formula (00A) and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
    Type: Application
    Filed: March 9, 2022
    Publication date: June 30, 2022
    Applicant: Genentech, Inc.
    Inventors: Yun-Xing Cheng, Paul Gibbons, Terry Kellar, Wei Li, Rohan Mendonca, Po-wai Yuen, Mark Edward Zak, Lei Zhang
  • Publication number: 20220106322
    Abstract: Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Applicant: Genentech, Inc.
    Inventors: Mark Edward Zak, Naomi S. Rajapaksa, Yun-Xing Cheng, Wei Li, Daniel G.M. Shore, F. Anthony Romero, Marian C. Bryan
  • Patent number: 11258267
    Abstract: A method and apparatus is disclosed relating to smart Microgrids or off-grid solar systems with grid power integration supported by AC assisted off-grid power inverters that can (1) intelligently and selectively pull power from one or multiple DC sources including solar panels, wind generators, and batteries based on certain criteria; (2) invert DC power to AC power as generated AC power; (3) intelligently pull power from a connected AC source including grid AC, a gas generator, or a wind generator as input AC power; (4) combine the generated AC power with the input AC power; (5) supply the combined AC power, or the generated AC power, or the input AC power to an off-grid circuit to power various types of AC loads; (6) send no power to the connected AC source; (7) maximize DC power production; (8) minimize the consumption of input AC power; and (9) achieve good system performance under DC and AC power variations and load changes.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: February 22, 2022
    Assignee: CyboEnergy, Inc.
    Inventors: George Shu-Xing Cheng, Steven L. Mulkey, Andrew J. Chow
  • Publication number: 20220050225
    Abstract: Provided are a metasurface primary mirror, a metasurface secondary mirror, a method for manufacturing a metasurface primary mirror, a method for manufacturing a metasurface secondary mirror, and an optical system. The metasurface primary mirror, manufactured by using the method for manufacturing a metasurface primary mirror, includes a transparent substrate which includes a primary mirror metasurface pattern on the transparent substrate. The primary mirror metasurface is configured to satisfy a primary mirror phase distribution such that incident light reflected by a metasurface secondary mirror onto the metasurface primary mirror is reflected and focused.
    Type: Application
    Filed: November 22, 2018
    Publication date: February 17, 2022
    Inventors: Guixin Li, Xuan Liu, Junhong Deng, Jinghui Li, Xing Cheng
  • Publication number: 20220024945
    Abstract: Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
    Type: Application
    Filed: September 29, 2021
    Publication date: January 27, 2022
    Applicant: Genentech, Inc.
    Inventors: Mark ZAK, F. Anthony ROMERO, Yun-Xing CHENG, Wei LI
  • Patent number: 11155557
    Abstract: Compounds of Formula (IA), or a pharmaceutically acceptable salt thereof, and methods of use as Janus kinase inhibitors are described herein.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: October 26, 2021
    Assignee: Genentech, Inc.
    Inventors: F. Anthony Romero, Mark Zak, Guiling Zhao, Paul Gibbons, Wei Li, Yun-Xing Cheng, Po-Wai Yuen, Limin Cheng
  • Publication number: 20210216009
    Abstract: The present application discloses a method for preparing optical metasurfaces, wherein the method is performed based on nano-imprinting, and the template used in the method is an imprinting template with patterns of meta-atoms. The method for preparing optical metasurfaces provided by the present application can replace the electron beam lithography method used in fabricating meta-atoms, greatly reducing the costs, and greatly reducing the production time. The method provided by the present application significantly improves the production cost and the production time, achieving a low-cost, large-scale fabrication of metasurface-based optical elements within a short time, and having good industrialization prospects.
    Type: Application
    Filed: December 7, 2017
    Publication date: July 15, 2021
    Applicant: SOUTH UNIVERSITY OF SCIENCE AND UNIVERSITY OF CHINA
    Inventors: Xing Cheng, Guixin Li, Xin Zhuang, Junhong Deng
  • Publication number: 20210179564
    Abstract: Compounds of Formula (I): and salts thereof, and methods of use as Janus kinase inhibitors are described herein.
    Type: Application
    Filed: February 17, 2021
    Publication date: June 17, 2021
    Applicant: Genentech, Inc.
    Inventors: James John Crawford, Mark Zak, Terry Kellar, Yun-Xing Cheng, Wei Li, F. Anthony Romero, Paul Gibbons, Guiling Zhao, Gregory Hamilton, Simon Charles Goodacre
  • Publication number: 20210170409
    Abstract: A microfluidic chip for circulating tumor cell separation, comprising a first shell layer, a second shell layer, and a filter membrane between the first shell layer and the second shell layer. A first channel is formed between the filter membrane and the first shell layer; a second channel is formed between the filter membrane and the second shell layer; the first shell layer is provided with m input interfaces and n output interfaces, wherein m is greater than or equal to 1 and n is greater than or equal to 1; the second shell layer is provided with x input interfaces and y output interfaces, wherein x is greater than or equal to 1 and y is greater than or equal to 1. The chip is used for circulating tumor cell separation to achieve high flux, high efficiency, and a simple method, and facilitate promotion.
    Type: Application
    Filed: March 16, 2018
    Publication date: June 10, 2021
    Inventors: Xing Cheng, Youwei Jiang, Zhenming Yu, Xinglong Huang, Rifei Chen
  • Patent number: 10884343
    Abstract: Disclosed are a system and method for micro-nano machining by femtosecond laser two-photon polymerization. The system includes: a femtosecond laser, an external light path modulation unit, an image capture apparatus, a focusing lens, a displacement platform, a computer and a monitoring apparatus, where the image capture apparatus is configured to capture cross-section graphs of a three-dimensional micro-nano device layer by layer, so that modulated femtosecond lasers form parallel beams arranged according to all layers of the cross-section graphs.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: January 5, 2021
    Assignee: South University of Science and Technology of China
    Inventors: Xing Cheng, Dehu Cui, Ziping Li, Jing Ming
  • Publication number: 20200399275
    Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
    Type: Application
    Filed: June 16, 2020
    Publication date: December 24, 2020
    Applicant: Genentech, Inc.
    Inventors: Mark Edward Zak, Naomi S. Rajapaksa, Yun-Xing Cheng, Jessica Grandner, Daniel G.M. Shore, Marian C. Bryan